The Battle Over Essure

The Washington Post, July 26, 2017: Essure was marketed as an easy, non-invasive permanent contraception (sterilization), but many women reported pain, serious harm requiring surgery, and pregnancies. It wasn’t until patients and public health experts like NCHR met with FDA officials that the agency added warnings. Some women needed surgery to remove the device, and lawsuits claimed FDA approved Essure based on poorly conducted clinical trials.

Read More »